Annual Short Term Debt
$1.14 M
-$640.00 K-36.02%
31 December 2023
Summary:
Castle Biosciences annual short term debt is currently $1.14 million, with the most recent change of -$640.00 thousand (-36.02%) on 31 December 2023. During the last 3 years, it has fallen by -$42.00 thousand (-3.56%). CSTL annual short term debt is now -80.51% below its all-time high of $5.83 million, reached on 31 December 2019.CSTL Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$1.75 M
+$519.00 K+42.33%
30 September 2024
Summary:
Castle Biosciences quarterly short term debt is currently $1.75 million, with the most recent change of +$519.00 thousand (+42.33%) on 30 September 2024. Over the past year, it has increased by +$608.00 thousand (+53.47%). CSTL quarterly short term debt is now -82.55% below its all-time high of $10.00 million, reached on 30 June 2020.CSTL Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +53.5% |
| 3 y3 years | -3.6% | +48.0% |
| 5 y5 years | -80.5% | -70.1% |
CSTL Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -36.0% | at low | -11.2% | +60.0% |
| 5 y | 5 years | -80.5% | -82.5% | ||
| alltime | all time | -80.5% | -82.5% |
Castle Biosciences Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.75 M(+42.3%) |
| June 2024 | - | $1.23 M(+3.1%) |
| Mar 2024 | - | $1.19 M(+4.6%) |
| Dec 2023 | $1.14 M(-36.0%) | $1.14 M(+4.2%) |
| Sept 2023 | - | $1.09 M(-44.5%) |
| June 2023 | - | $1.97 M(+10.5%) |
| Mar 2023 | - | $1.78 M(+0.1%) |
| Dec 2022 | $1.78 M | $1.78 M(+15.8%) |
| Sept 2022 | - | $1.53 M(+26.8%) |
| June 2022 | - | $1.21 M(+1.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $1.20 M(+1.7%) |
| Dec 2021 | $1.18 M(>+9900.0%) | $1.18 M(>+9900.0%) |
| Dec 2020 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2020 | - | $10.00 M(0.0%) |
| June 2020 | - | $10.00 M(+20.0%) |
| Mar 2020 | - | $8.33 M(+42.9%) |
| Dec 2019 | $5.83 M(+483.3%) | $5.83 M(+75.0%) |
| Sept 2019 | - | $3.33 M(-36.6%) |
| June 2019 | - | $5.26 M |
| Dec 2017 | $1.00 M | - |
FAQ
- What is Castle Biosciences annual short term debt?
- What is the all time high annual short term debt for Castle Biosciences?
- What is Castle Biosciences quarterly short term debt?
- What is the all time high quarterly short term debt for Castle Biosciences?
- What is Castle Biosciences quarterly short term debt year-on-year change?
What is Castle Biosciences annual short term debt?
The current annual short term debt of CSTL is $1.14 M
What is the all time high annual short term debt for Castle Biosciences?
Castle Biosciences all-time high annual short term debt is $5.83 M
What is Castle Biosciences quarterly short term debt?
The current quarterly short term debt of CSTL is $1.75 M
What is the all time high quarterly short term debt for Castle Biosciences?
Castle Biosciences all-time high quarterly short term debt is $10.00 M
What is Castle Biosciences quarterly short term debt year-on-year change?
Over the past year, CSTL quarterly short term debt has changed by +$608.00 K (+53.47%)